Evidence map›Paper›PMID 41364552›Full record

Trial reportThe Journal of clinical investigation2026

Age modifies the association between sex and the plasma inflammatory proteome in treated HIV.

Rebecca A Abelman, Samuel R Schnittman, Natalia Faraj Murad, Adam B Olshen, Gabriele B Beck-Engeser, Noah Aquino, Gabrielle C Ambayec, Edward R Cachay, Joseph J Eron, Michael S Saag and 9 more

Abstract readClinical Trial
In one paragraph

Trial report in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Rebecca A AbelmanUCSF, San Francisco, California, USA.
Samuel R SchnittmanAmgen, Thousand Oaks, California, USA.
Natalia Faraj MuradUCSF, San Francisco, California, USA.
Adam B OlshenUCSF, San Francisco, California, USA.
Gabriele B Beck-EngeserUCSF, San Francisco, California, USA.
Noah AquinoUCSF, San Francisco, California, USA.
Gabrielle C AmbayecUCSF, San Francisco, California, USA.
Edward R CachayMayo Clinic, Scottsdale, Arizona, USA.
Joseph J EronUniversity of North Carolina, Chapel Hill, North Carolina, USA.
Michael S SaagUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
Robin M NanceUniversity of Washington, Seattle, Washington, USA.
Joseph A DelaneyUniversity of Washington, Seattle, Washington, USA.
Stephanie A RudermanUniversity of Washington, Seattle, Washington, USA.
Richard D MooreJohns Hopkins University, Baltimore, Maryland, USA.
Kenneth H MayerThe Fenway Institute, Boston, Massachusetts, USA.
Jeffrey M JacobsonCase Western Reserve University, Cleveland, Ohio, USA.
Heidi M CraneUniversity of Washington, Seattle, Washington, USA.
Peter W HuntUCSF, San Francisco, California, USA.
CFAR Network of Integrated Clinical Systems (CNICS) Group

Funding

Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6M
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patientsR01HL126538 · NHLBI · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., CROTHERS, KRISTINA ANNE · 2015 to 2025
$5.1M
Sex differences in the contribution of cerebrovascular injury and immune activation to neurocognitive impairment in HIV infectionR01NS126086 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Felicia C. Chow · 2022 to 2026
$3.2M
Impact of Asymptomatic CMV on Cardiovascular Event Risk in Treated HIVR01HL180319 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2025 to 2025
$3.0M
The study of Eicosanoids as Novel Inflammatory Mediators of CVD in Men and Women with HIVR01HL167658 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Claudia Martinez, Inga Peter · 2023 to 2026
$2.8M
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)K12HL143961 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUE, PRISCILLA Y., HUANG, LAURENCE · 2018 to 2022
$1.8M
Persistent Functional Immune Defects in Treated HIV InfectionK24AI145806 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2020 to 2024
$921k
Plasma Proteomic and Metabolomic Predictors of Vascular Disease in Treated HIVR56HL160457 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2021 to 2021
$789k
NHLBI NIH HHS K12 HL143961NHLBI NIH HHS R01 HL126538NHLBI NIH HHS R01 HL167658NHLBI NIH HHS R01 HL180319NHLBI NIH HHS R56 HL160457NIAID NIH HHS K24 AI145806NIAID NIH HHS P30 AI027763NIAID NIH HHS R24 AI067039NINDS NIH HHS R01 NS126086
6 · The paper itself

Abstract

BACKGROUNDAmong antiretroviral therapy-suppressed (ART-suppressed) people with HIV (PWH), women have higher levels of some inflammatory markers than men, but the effect of sex on the inflammatory proteome, and whether age modifies these differences, remain unclear.METHODSPlasma inflammatory protein levels were assessed in ART-suppressed PWH from the Center for AIDS Research Network of Integrated Clinical Systems. The relationship between sex and plasma proteins - including 22 interferon-α response pathway proteins - was assessed, adjusting for confounders and assessing interactions by age.RESULTSOf 922 participants, 162 (18%) were female. The median age was 47, above which the majority of women had undetectable plasma anti-Müllerian hormone levels, a biomarker of ovarian reserve. Age modified the influence of sex on the inflammatory proteome. Older age (>47) was associated with greater increases among women than men in 194 proteins. Interferon-α response proteins were higher in men in those ≤ 47 but higher in women in those > 47 (interaction P < 0.001). Among the 131 proteins associated with mortality risk (q < 0.05), only 5 differed by sex among those ≤ 47, while 79 differed by sex in those > 47, with nearly all being higher in women. Women had decreased mortality than men ≤ 47 (P < 0.001) but had similar mortality > 47 (P = 0.84).CONCLUSIONThe menopausal transition appears to increase systemic type I interferon responses and inflammation in women with HIV, which may contribute to a loss of female advantage in mortality.FUNDINGNIH National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases.

Indexed as

Blood ProteinsHIV InfectionsProteomeAdultAgedAge FactorsFemaleHumansInflammationMaleMiddle AgedSex FactorsBlood ProteinsProteomeAIDS/HIVInflammationProteomics

Identifiers

PMID41364552
PMCPMC12867131

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.